Table 3.
Improvement of immune-inflammatory indices.
| Index | Control group | Experimental group | P 2 value | ||
|---|---|---|---|---|---|
| d 0 | P 0 value | d 1 | P 1 value | ||
| ESR (mm/h) | -24.213 | 0.00 | -27.964 | 0.00 | 0.000 |
| CRP (mg/L) | -31.166 | 0.00 | -33.468 | 0.00 | 0.000 |
| IgA (g/L) | -11.682 | 0.00 | -13.162 | 0.00 | 0.027 |
| IgM (g/L) | -1.004 | 0.32 | -4.466 | 0.00 | 0.017 |
| IgG (g/L) | -13.731 | 0.00 | -16.249 | 0.00 | 0.003 |
| C3 (g/L) | -15.286 | 0.00 | -17.495 | 0.00 | 0.035 |
| C4 (g/L) | -20.878 | 0.00 | -23.099 | 0.00 | 0.000 |
| CCP (mmol/L) | -4.352 | 0.00 | -3.352 | 0.00 | 0.333 |
| RF (U/mL) | -16.528 | 0.00 | -15.815 | 0.00 | 0.432 |
Note: ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; IgA: immunoglobulin A; IgM: immunoglobulin M; IgG: immunoglobulin G; C3: complement C3; C4: complement C4; CCP: anticyclic citrullinated peptide; RF: rheumatoid factor. d0 is the difference in the control group before and after treatment. P0 is the comparison between the control group before and after treatment. d1 is the difference in the experimental group before and after treatment. P1 is the comparison between the experimental group before and after treatment. P2 is comparison between both groups after treatment.